Literature DB >> 11875074

Structural characterization of the M* partly folded intermediate of wild type and P138A aspartate aminotransferase from Escherichia coli.

Leila Birolo1, Fabrizio Dal Piaz, Piero Pucci, Gennaro Marino.   

Abstract

A combination of spectroscopic techniques, hydrogen/deuterium exchange, and limited proteolysis experiments coupled to mass spectrometry analysis was used to depict the topology of the monomeric M* partly folded intermediate of aspartate aminotransferase from Escherichia coli in wild type (WT) as well as in a mutant form in which the highly conserved cis-proline at position 138 was replaced by a trans-alanine (P138A). Fluorescence analysis indicates that, although M* is an off-pathway intermediate in the folding of WT aspartate aminotransferase from E. coli, it seems to coincide with an on-pathway folding intermediate for the P138A mutant. Spectroscopic data, hydrogen/deuterium exchange, and limited proteolysis experiments demonstrated the occurrence of conformational differences between the two M* intermediates, with P138A-M* being conceivably more compact than WT-M*. Limited proteolysis data suggested that these conformational differences might be related to a different relative orientation of the small and large domains of the protein induced by the presence of the cis-proline residue at position 138. These differences between the two M* species indicated that in WT-M* Pro138 is in the cis conformation at this stage of the folding process. Moreover, hydrogen/deuterium exchange results showed the occurrence of few differences in the native N(2) forms of WT and P138A, the spectroscopic features and crystallographic structures of which are almost superimposable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875074     DOI: 10.1074/jbc.M200650200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Conformational analysis of HAMLET, the folding variant of human alpha-lactalbumin associated with apoptosis.

Authors:  Annarita Casbarra; Leila Birolo; Giuseppe Infusini; Fabrizio Dal Piaz; Malin Svensson; Piero Pucci; Catharina Svanborg; Gennaro Marino
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

2.  The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition.

Authors:  Chiara Giommarelli; Valentina Zuco; Enrica Favini; Claudio Pisano; Fabrizio Dal Piaz; Nunziatina De Tommasi; Franco Zunino
Journal:  Cell Mol Life Sci       Date:  2009-12-29       Impact factor: 9.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.